Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick van Es

Showing results (101-110 of 153) with videos related to

Pageof 16
Sort By:
Blood|May 13, 2020
Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysisFrits I Mulder, Floris T M Bosch, Annie M Young, et al.
Journal of Thrombosis and Haemostasis : JTH|May 6, 2020
Incidence of venous thromboembolism in hospitalized patients with COVID-19Saskia Middeldorp, Michiel Coppens, Thijs F van Haaps, et al.
Journal of Thrombosis and Haemostasis : JTH|June 18, 2023
Contact system and intrinsic pathway activation in patients with advanced pancreatic cancer: a prospective cohort studyFloris T M Bosch, Elena Campello, Frits I Mulder, et al.
European Heart Journal|December 7, 2021
Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory SocietyFrederikus A Klok, Walter Ageno, Cihan Ay, et al.
Journal of Thrombosis and Haemostasis : JTH|December 21, 2025
The win ratio for evaluating edoxaban versus dalteparin for cancer-associated venous thromboembolism: an analysis of the randomized Hokusai VTE cancer trialNick van Es, Luuk J J Scheres, Kristen M Sanfilippo, et al.
Annals of Internal Medicine|May 17, 2016
Wells Rule and d-Dimer Testing to Rule Out Pulmonary Embolism: A Systematic Review and Individual-Patient Data Meta-analysisNick van Es, Tom van der Hulle, Josien van Es, et al.
Lancet (London, England)|November 10, 2022
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trialIngrid M Bistervels, Andrea Buchmüller, Hanke M G Wiegers, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical ExtentMarjolein P A Brekelmans, Harry R Büller, Michele F Mercuri, et al.
Journal of Thrombosis and Haemostasis : JTH|March 6, 2025
Treatment and outcomes after on-treatment recurrent venous thromboembolism in patients with cancer: a post hoc analysis of the Hokusai venous thromboembolism cancer studyVincent R Lanting, Kika van Bergen En Henegouwen, Floris T M Bosch, et al.
Annals of Internal Medicine|August 23, 2017
Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis of Individual Patient DataNick van Es, Grégoire Le Gal, Hans-Martin Otten, et al.
Pageof 16

Showing results (101-110 of 153) with videos related to

Sort By:
Pageof 16
Blood|May 13, 2020
Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysisFrits I Mulder, Floris T M Bosch, Annie M Young, et al.
Journal of Thrombosis and Haemostasis : JTH|May 6, 2020
Incidence of venous thromboembolism in hospitalized patients with COVID-19Saskia Middeldorp, Michiel Coppens, Thijs F van Haaps, et al.
Journal of Thrombosis and Haemostasis : JTH|June 18, 2023
Contact system and intrinsic pathway activation in patients with advanced pancreatic cancer: a prospective cohort studyFloris T M Bosch, Elena Campello, Frits I Mulder, et al.
European Heart Journal|December 7, 2021
Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory SocietyFrederikus A Klok, Walter Ageno, Cihan Ay, et al.
Journal of Thrombosis and Haemostasis : JTH|December 21, 2025
The win ratio for evaluating edoxaban versus dalteparin for cancer-associated venous thromboembolism: an analysis of the randomized Hokusai VTE cancer trialNick van Es, Luuk J J Scheres, Kristen M Sanfilippo, et al.
Annals of Internal Medicine|May 17, 2016
Wells Rule and d-Dimer Testing to Rule Out Pulmonary Embolism: A Systematic Review and Individual-Patient Data Meta-analysisNick van Es, Tom van der Hulle, Josien van Es, et al.
Lancet (London, England)|November 10, 2022
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trialIngrid M Bistervels, Andrea Buchmüller, Hanke M G Wiegers, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical ExtentMarjolein P A Brekelmans, Harry R Büller, Michele F Mercuri, et al.
Journal of Thrombosis and Haemostasis : JTH|March 6, 2025
Treatment and outcomes after on-treatment recurrent venous thromboembolism in patients with cancer: a post hoc analysis of the Hokusai venous thromboembolism cancer studyVincent R Lanting, Kika van Bergen En Henegouwen, Floris T M Bosch, et al.
Annals of Internal Medicine|August 23, 2017
Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis of Individual Patient DataNick van Es, Grégoire Le Gal, Hans-Martin Otten, et al.
Pageof 16